Abstract

Soft tissue sarcomas are rare but aggressive tumor behavior. There are many histological subtypes. Often, it is seen in the extremity and retroperitoneal regions. Surgical treatment is important to maintain function. Generally, radiotherapy after surgery is important. Compartment of the tumor by surgery and radiotherapy are treated. Fibrosis is the most common side effects. Current local treatment for soft tissue sarcomas are discussed in this review

Keywords

• Soft tissue sarcomas, Radiotherapy

Yumuşak doku sarkomlarında güncel radyoterapi ve lokal tedavi

Abstract

Yumuşak doku sarkomları nadir görülen ancak agresif seyreden tümörlerdir. Çok sayıda histopatolojik alt tipi vardır. Ekstremite ve retroperitonal bölgelerde sıklıkla görülür. Cerrahi tedavide fonksiyon korumak önemlidir. Genellikle cerrahi sonrası radyoterapi önemlidir. Tümörün bulunduğu kompartıman cerrahi olarak ve radyoterapi olarak tedavi edilir. Fibrozis en sık gözlenen yan etkidir. Bu derlemede yumuşak doku sarkomlarında güncel lokal tedaviler tartışılmıştır

Keywords

• Yumuşak doku sarkomları, Radyoterapi

References

1. 1. Rajiah P , Ilaslan H, Sundaram M. Imaging of sarcomas of pelvic bones. Semin Ultrasound CT MR. 2011; 32: 433-41.
2. 2. De Schepper AM, De Beuckeleer L, Vandevenne J, Somville J. Magnetic resonance imaging of soft tissue tumors. Eur Radiol. 2000;10(2):213-23.
3. 3. Heslin MJ, Smith JK. Imaging of soft tissue sarcomas. Surg Oncol Clin N Am. 1999; 8: 91-107.
4. 4. Holzapfel K, Regler J, Baum T, et al. Local Staging of Soft-Tissue Sarcoma: Emphasis on Assessment of Neurovascular Encasement-Value of MR Imaging in 174 Confirmed Cases. Radiology. 2015; 275: 501-9.
5. 5. Sheikhbahaei S, Marcus C, Hafezi-Nejad N, et al. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas. PET Clin. 2015; 10:375-93.
6. 6. Rubin BP1 , Goldblum JR. Pathology of soft tissue sarcoma. J Natl Compr Canc Netw. 2007;5: 411-8.
7. 7. Hiniker SM, Donaldson SS. Recent advances in understanding and managing rhabdomyosarcoma. F1000Prime Rep. 2015 12; 7: 59.
8. 8. Radzikowska J, Kukwa W, Kukwa A, et al. Rhabdomyosarcoma of the head and neck in children. Contemp Oncol (Pozn). 2015; 19: 98-107.

9. 9. Baldini EH, Wang D, Haas RL, et al. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015; 92: 602-12.
10. 10. Dickie CI, Haas R, O'Sullivan B. Adjuvant radiation for soft tissue sarcomas. Am Soc Clin Oncol Educ Book. 2015; 35: 634-42.
11. 11. De Amorim Bernstein K, Delaney TF. Role of radiation therapy for non-extremity soft tissue sarcomas. J Surg Oncol. 2015;111: 604-14.
12. 12. Kachare SD, Brinkley J, Vohra NA, et al. Radiotherapy associated with improved survival for highgrade sarcoma of the extremity. J Surg Oncol. 2015; 112: 338-43
13. 13. Dickie CI, Haas R, O'Sullivan B. Adjuvant radiation for soft tissue sarcomas. Am Soc Clin Oncol Educ Book. 2015; 35: 634-42
14. 14. Cambeiro M, Calvo FA, Aristu JJ, et al. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome. Radiother Oncol. 2015;116: 316-22.
15. 15. Keole S, Ashman JB, Daniels TB. Proton therapy for sarcomas. Cancer J. 2014; 20: 409-14.
16. 16 El-Bared N, Wong P, Wang D. Soft tissue sarcoma and radiation therapy advances, impact on toxicity. Curr Treat Options Oncol. 2015; 16: 19.